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Drug-Free Antibacterial Hybrid Biopolymers for Medical Applications
Ayesha Idrees1, 2, Richard Viebahn2, Gianluca Ciardelli1, Valeria Chiono1, Jochen Salber2
1Department of Mechanical and Aerospace Engineering (DIMEAS), Politecnico di Torino, Italy 
2 UMC Knappschaftskrankenhaus GmbH, Clinic of Surgery, Hospital of the Ruhr-University, Bochum, Germany
A bacterial colonized human skin equivalent (c-HSE)
The aim of this study was the development of a human skin model and human skin wound infection model for the bio-evaluation of
antimicrobial biomaterials intended for wound healing purposes. The three-dimensional in vitro models will represent advanced and complex
systems to perform more reliable preclinical studies. These models will be employed for in vitro screening of both antibacterial activity as well
as cytocompatibility of new biomaterials and wound dressings to optimize their in vivo performances. In the study, the 3D systems were
developed and their structure was characterized. The antibacterial activity and cytotoxicity of a model wound dressing releasing Ag+ was
analyzed in the models.
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S. aureus Colonized Human Skin Equivalent - In Vitro Bio-evaluation Tool for 
Antibacterial Polymers: ESR14
Optimizing the dermal part of human skin: Z-stacked imaging
revealed the filopodia like morphology and a uniform distribution
of human fibroblasts at different planes inside a Col-I matrix.
Fluorescent microscopic images show cell nuclei stained with
DAPI and cytoskeletal F-actin stained with Phalloidin. Scale
bar=100 µm
H&E stained cross 
section of in vitro HSE 
model:
- Epidermal layer (1)
- Dermal layer (2)
The HSE epidermis has 
a characteristic 
structure: Stratum 
corneum, granulosum, 
spinosum and basale.
Histological Analysis of the HSE 
Immunohistochemistry of the 3D Human Skin Model 
Ultrastructure Analysis   S. aureus-colonized HSE    
TEM image:
- Collagen-I fibres 
(Col I)
- Epidermal-
Dermal Junction 
(DEJ).
- DEJ presents 
lamina lucida 
(LL) and lamina 
densa (LD).
Antibacterial Analysis Cytocompatibility Analysis 
Inoculated bacteria adhere to the 
dermal surface, colonize, and 
replicate to make large structures 
of  biofilm.
Big arrows: Bacteria located 
within a biofilm matrix inside the 
dermis. 
Small arrows: Bacteria 
surrounding keratinocytes in 
epidermis.
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Supervisors’ Emails: gianluca.ciardelli@polito.it; valeria.chiono@polito.it; 
jochen.salber@kk-bochum.de; jochen.salber@hotmail.com
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Cell viability measuring in the 3D system. The 3D skin model was exposed to a range of
silver ion concentrations (Ag+) for a period of 24 hours.
A commercially available Ag+ releasing wound dressing served the purpose of a model
material and was tested in a 3D system along with its control material (without Ag+).
The graph demonstrates the treatment of infected skin equivalents with a
commercially available Ag+ releasing wound dressing. Skin equivalents were infected
with S.aureus and thereafter, Ag+ releasing wound dressing or Ag+ in PBS was
applied onto the skin equivalents.
Conclusion: Development of colonized human skin equivalent (c-HSE); Risk assessment platform for cytocompatibility evaluation; Efficacy assessment of antibacterial 
materials; Comparison of 2D vs. 3D systems; Understanding “Host-Pathogen Interaction”; Development of complex skin models.
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IHC verification of the Human
Skin Equivalent (HSE):
(a) Keratin 14 (K14) red;
(b) Keratin 10 (K10) green;
(c) Ki67 (arrows) green;
(d) Laminin 5 (Lam5) green;
Cell nuclei are shown in blue by
using DAPI staining. Laminin 5
is used as a marker of dermal-
epidermal junction (DEJ) and
appeared as a thin line.
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